Restricted accessLetterFirst published online 2020-6
Unintended Impact of US Food and Drug Administration Recalls on the Use of Contaminated and Non-Contaminated Angiotensin Receptor Blockers Among Medicaid Beneficiaries
ByrdJBChertowGMBhallaV.Hypertension hot potato—anatomy of the angiotensin-receptor blocker recalls. N Engl J Med. 2019;380:1589-1591. doi:10.1056/NEJMp1901657
3.
GunasekaranPMChertowGMBhallaVByrdJB.Current status of angiotensin receptor blocker recalls. Hypertension. 2019;74:1275-1278. doi:10.1161/HYPERTENSIONAHA.119.13955
4.
JackeviciusCAKrumholzHMChongA, et al. Population impact of generic valsartan recall. Circulation. 2020;141:411-413. doi:10.1161/CIRCULATIONAHA.119.044494
5.
Al-KindiSGOliveiraGH.Abrupt increase in reporting of neoplasms associated with valsartan after medication recall. Circ Cardiovasc Qual Outcomes. 2019;12:e005536. doi:10.1161/CIRCOUTCOMES.119.005536
